389 related articles for article (PubMed ID: 33754916)
1. MR-proAdrenomedullin as a predictor of renal replacement therapy in a cohort of critically ill patients with COVID-19.
Roedl K; Jarczak D; Fischer M; Haddad M; Boenisch O; de Heer G; Burdelski C; Frings D; Sensen B; Karakas M; Kluge S; Nierhaus A
Biomarkers; 2021 Jul; 26(5):417-424. PubMed ID: 33754916
[TBL] [Abstract][Full Text] [Related]
2. Effectiveness of mid-regional pro-adrenomedullin (MR-proADM) as prognostic marker in COVID-19 critically ill patients: An observational prospective study.
Montrucchio G; Sales G; Rumbolo F; Palmesino F; Fanelli V; Urbino R; Filippini C; Mengozzi G; Brazzi L
PLoS One; 2021; 16(2):e0246771. PubMed ID: 33556140
[TBL] [Abstract][Full Text] [Related]
3. The vasoactive peptide MR-pro-adrenomedullin in COVID-19 patients: an observational study.
Gregoriano C; Koch D; Kutz A; Haubitz S; Conen A; Bernasconi L; Hammerer-Lercher A; Saeed K; Mueller B; Schuetz P
Clin Chem Lab Med; 2021 Apr; 59(5):995-1004. PubMed ID: 33554516
[TBL] [Abstract][Full Text] [Related]
4. Acute Kidney Injury and Renal Replacement Therapy in Critically Ill COVID-19 Patients: Risk Factors and Outcomes: A Single-Center Experience in Brazil.
Doher MP; Torres de Carvalho FR; Scherer PF; Matsui TN; Ammirati AL; Caldin da Silva B; Barbeiro BG; Carneiro FD; Corrêa TD; Ferraz LJR; Dos Santos BFC; Pereira VG; Batista MC; Monte JCM; Santos OFP; Bellomo R; Serpa Neto A; Durão MS
Blood Purif; 2021; 50(4-5):520-530. PubMed ID: 33341806
[TBL] [Abstract][Full Text] [Related]
5. High levels of mid-regional proadrenomedullin in ARDS COVID-19 patients: the experience of a single, Italian Center.
Benedetti I; Spinelli D; Callegari T; Bonometti R; Molinaro E; Novara E; Cassinari M; Frino C; Guaschino R; Boverio R; Lauritano EC
Eur Rev Med Pharmacol Sci; 2021 Feb; 25(3):1743-1751. PubMed ID: 33629344
[TBL] [Abstract][Full Text] [Related]
6. Mid-regional proadrenomedullin: An early marker of response in critically ill patients with severe community-acquired pneumonia?
Pereira JM; Azevedo A; Basílio C; Sousa-Dias C; Mergulhão P; Paiva JA
Rev Port Pneumol (2006); 2016; 22(6):308-314. PubMed ID: 27160747
[TBL] [Abstract][Full Text] [Related]
7. Effectiveness of mid-regional pro-adrenomedullin, compared to other biomarkers (including lymphocyte subpopulations and immunoglobulins), as a prognostic biomarker in COVID-19 critically ill patients: New evidence from a 15-month observational prospective study.
Montrucchio G; Sales G; Balzani E; Lombardo D; Giaccone A; Cantù G; D'Antonio G; Rumbolo F; Corcione S; Simonetti U; Bonetto C; Zanierato M; Fanelli V; Filippini C; Mengozzi G; Brazzi L
Front Med (Lausanne); 2023; 10():1122367. PubMed ID: 37035317
[TBL] [Abstract][Full Text] [Related]
8. Prediction of the renal replacement therapy requirement in mechanically ventilated critically ill patients by combining biomarkers for glomerular filtration and tubular damage.
Pipili C; Ioannidou S; Tripodaki ES; Parisi M; Douka E; Vasileiadis I; Joannidis M; Nanas S
J Crit Care; 2014 Aug; 29(4):692.e7-13. PubMed ID: 24674762
[TBL] [Abstract][Full Text] [Related]
9. Biomarkers and clinical scores to identify patient populations at risk of delayed antibiotic administration or intensive care admission.
Gonzalez Del Castillo J; Wilson DC; Clemente-Callejo C; Román F; Bardés-Robles I; Jiménez I; Orviz E; Dastis-Arias M; Espinosa B; Tornero-Romero F; Giol-Amich J; González V; Llopis-Roca F;
Crit Care; 2019 Oct; 23(1):335. PubMed ID: 31665092
[TBL] [Abstract][Full Text] [Related]
10. Biomarker Predictors of Adverse Acute Kidney Injury Outcomes in Critically Ill Patients: The Dublin Acute Biomarker Group Evaluation Study.
McMahon BA; Galligan M; Redahan L; Martin T; Meaney E; Cotter EJ; Murphy N; Hannon C; Doran P; Marsh B; Nichol A; Murray PT
Am J Nephrol; 2019; 50(1):19-28. PubMed ID: 31203271
[TBL] [Abstract][Full Text] [Related]
11. Endothelium-associated biomarkers mid-regional proadrenomedullin and C-terminal proendothelin-1 have good ability to predict 28-day mortality in critically ill patients with SARS-CoV-2 pneumonia: A prospective cohort study.
van Oers JAH; Kluiters Y; Bons JAP; de Jongh M; Pouwels S; Ramnarain D; de Lange DW; de Grooth HJ; Girbes ARJ
J Crit Care; 2021 Dec; 66():173-180. PubMed ID: 34340901
[TBL] [Abstract][Full Text] [Related]
12. Severe acute kidney injury in critically ill COVID-19 patients.
Piñeiro GJ; Molina-Andújar A; Hermida E; Blasco M; Quintana LF; Rojas GM; Mercadal J; Castro P; Sandoval E; Andrea R; Fernández J; Badia JR; Soriano A; Poch E;
J Nephrol; 2021 Apr; 34(2):285-293. PubMed ID: 33387345
[TBL] [Abstract][Full Text] [Related]
13. Mid-regional pro-adrenomedullin predicts poor outcome in non-selected patients admitted to an intensive care unit.
Bellia C; Agnello L; Lo Sasso B; Bivona G; Raineri MS; Giarratano A; Ciaccio M
Clin Chem Lab Med; 2019 Mar; 57(4):549-555. PubMed ID: 30157027
[TBL] [Abstract][Full Text] [Related]
14. Early acute kidney injury and transition to renal replacement therapy in critically ill patients with SARS-CoV-2 requiring veno-venous extracorporeal membrane oxygenation.
Roedl K; De Rosa S; Fischer M; Braunsteiner J; Schmidt-Lauber C; Jarczak D; Huber TB; Kluge S; Wichmann D
Ann Intensive Care; 2023 Nov; 13(1):115. PubMed ID: 37999776
[TBL] [Abstract][Full Text] [Related]
15. AKI Treated with Renal Replacement Therapy in Critically Ill Patients with COVID-19.
Gupta S; Coca SG; Chan L; Melamed ML; Brenner SK; Hayek SS; Sutherland A; Puri S; Srivastava A; Leonberg-Yoo A; Shehata AM; Flythe JE; Rashidi A; Schenck EJ; Goyal N; Hedayati SS; Dy R; Bansal A; Athavale A; Nguyen HB; Vijayan A; Charytan DM; Schulze CE; Joo MJ; Friedman AN; Zhang J; Sosa MA; Judd E; Velez JCQ; Mallappallil M; Redfern RE; Bansal AD; Neyra JA; Liu KD; Renaghan AD; Christov M; Molnar MZ; Sharma S; Kamal O; Boateng JO; Short SAP; Admon AJ; Sise ME; Wang W; Parikh CR; Leaf DE;
J Am Soc Nephrol; 2021 Jan; 32(1):161-176. PubMed ID: 33067383
[TBL] [Abstract][Full Text] [Related]
16. Mid-Regional Pro-Adrenomedullin, Methemoglobin and Carboxyhemoglobin as Prognosis Biomarkers in Critically Ill Patients with COVID-19: An Observational Prospective Study.
Oblitas CM; Galeano-Valle F; Ramírez-Navarro J; López-Cano J; Monterrubio-Manrique Á; García-Gámiz M; Sancho-González M; Arenal-López S; Álvarez-Sala Walther LA; Demelo-Rodríguez P
Viruses; 2021 Dec; 13(12):. PubMed ID: 34960714
[TBL] [Abstract][Full Text] [Related]
17. COVID-19-associated acute kidney injury patients treated with renal replacement therapy in the intensive care unit: A multicenter study in São Paulo, Brazil.
Samaan F; Carneiro de Paula E; de Lima Souza FBG; Mendes LFC; Rossi PRG; Freitas RAP; Nakagawa FT; Maciel AT; Aranha S; Osawa E; Konigsfeld HP; da Silva RG; de Souza RBC; Coutinho SM; Vieira TD; Thomaz KB; Flato EMS; da Silva RC; Andrade LV; Badaoui M; Badaoui EP; Goes MÂ; do Amaral SH; Cunha K; Muniz IM; Sampaio JS; Durão Junior MS; Zanetta DMT; Burdmann EA
PLoS One; 2022; 17(1):e0261958. PubMed ID: 35030179
[TBL] [Abstract][Full Text] [Related]
18. Mid-Regional Pro-Adrenomedullin Can Predict Organ Failure and Prognosis in Sepsis?
Spoto S; Basili S; Cangemi R; D'Avanzo G; Lupoi DM; Romiti GF; Argemi J; Yuste JR; Lucena F; Locorriere L; Masini F; Testorio G; Calarco R; Fogolari M; Francesconi M; Battifoglia G; Costantino S; Angeletti S
Int J Mol Sci; 2023 Dec; 24(24):. PubMed ID: 38139258
[TBL] [Abstract][Full Text] [Related]
19. High value of mid-regional proadrenomedullin in COVID-19: A marker of widespread endothelial damage, disease severity, and mortality.
Spoto S; Agrò FE; Sambuco F; Travaglino F; Valeriani E; Fogolari M; Mangiacapra F; Costantino S; Ciccozzi M; Angeletti S
J Med Virol; 2021 May; 93(5):2820-2827. PubMed ID: 33200824
[TBL] [Abstract][Full Text] [Related]
20. Clinical Utility of Midregional Proadrenomedullin in Patients with COVID-19.
Lo Sasso B; Gambino CM; Scichilone N; Giglio RV; Bivona G; Scazzone C; Muratore R; Milano S; Barbagallo M; Agnello L; Ciaccio M
Lab Med; 2021 Sep; 52(5):493-498. PubMed ID: 33928380
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
